A citation-based method for searching scientific literature

Violena Pietrobon, Alessandra Cesano, Francesco Marincola, Jakob Nikolas Kather. Front Immunol 2021
Times Cited: 5







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting.
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, James J Harding, Christopher A Barker, Joseph A O'Donoghue, Martha Ziolkowska, Shutian Ruan, Serge K Lyashchenko, Frank Tsai,[...]. J Nucl Med 2020
63
60

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer.
A N Niemeijer, D Leung, M C Huisman, I Bahce, O S Hoekstra, G A M S van Dongen, R Boellaard, S Du, W Hayes, R Smith,[...]. Nat Commun 2018
154
60

A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Alex D Waldman, Jill M Fritz, Michael J Lenardo. Nat Rev Immunol 2020
399
60

Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.
Khun Visith Keu, Timothy H Witney, Shahriar Yaghoubi, Jarrett Rosenberg, Anita Kurien, Rachel Magnusson, John Williams, Frezghi Habte, Jamie R Wagner, Stephen Forman,[...]. Sci Transl Med 2017
154
60

Regulation and Function of the PD-L1 Checkpoint.
Chong Sun, Riccardo Mezzadra, Ton N Schumacher. Immunity 2018
596
40

18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival.
Giulia Polverari, Francesco Ceci, Valentina Bertaglia, Maria Lucia Reale, Osvaldo Rampado, Elena Gallio, Roberto Passera, Virginia Liberini, Paola Scapoli, Vincenzo Arena,[...]. Cancers (Basel) 2020
24
40

Roles of the immune system in cancer: from tumor initiation to metastatic progression.
Hugo Gonzalez, Catharina Hagerling, Zena Werb. Genes Dev 2018
468
40

Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.
Jianyuan Zhang, Xinming Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Jianfang Wang, Yingchen Wang, Meng Dai, Jingya Han. Eur J Nucl Med Mol Imaging 2020
44
40

Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.
M Tazdait, L Mezquita, J Lahmar, R Ferrara, F Bidault, S Ammari, C Balleyguier, D Planchard, A Gazzah, J C Soria,[...]. Eur J Cancer 2018
158
40

Introduction to Radiomics.
Marius E Mayerhoefer, Andrzej Materka, Georg Langs, Ida Häggström, Piotr Szczypiński, Peter Gibbs, Gary Cook. J Nucl Med 2020
79
40

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
40

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
Hoda Anwar, Christos Sachpekidis, Julia Winkler, Annette Kopp-Schneider, Uwe Haberkorn, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss. Eur J Nucl Med Mol Imaging 2018
77
40

Assessing PD-L1 Expression Level by Radiomic Features From PET/CT in Nonsmall Cell Lung Cancer Patients: An Initial Result.
Mengmeng Jiang, Dazhen Sun, Yinglong Guo, Yixian Guo, Jie Xiao, Lisheng Wang, Xiuzhong Yao. Acad Radiol 2020
27
40

Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis.
Hyo Jung Park, Kyung Won Kim, Junhee Pyo, Chong Hyun Suh, Shinkyo Yoon, Hiroto Hatabu, Mizuki Nishino. Radiology 2020
19
40

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.
Il Minn, David J Huss, Hye-Hyun Ahn, Tamara M Chinn, Andrew Park, Jon Jones, Mary Brummet, Steven P Rowe, Polina Sysa-Shah, Yong Du,[...]. Sci Adv 2019
42
40

Novel (89)Zr cell labeling approach for PET-based cell trafficking studies.
Aditya Bansal, Mukesh K Pandey, Yunus E Demirhan, Jonathan J Nesbitt, Ruben J Crespo-Diaz, Andre Terzic, Atta Behfar, Timothy R DeGrado. EJNMMI Res 2015
65
40

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
40



Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.
Richard Tavaré, Melissa N McCracken, Kirstin A Zettlitz, Scott M Knowles, Felix B Salazar, Tove Olafsen, Owen N Witte, Anna M Wu. Proc Natl Acad Sci U S A 2014
94
40

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
Jedd D Wolchok, Axel Hoos, Steven O'Day, Jeffrey S Weber, Omid Hamid, Celeste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol,[...]. Clin Cancer Res 2009
40

Reassessing Patterns of Response to Immunotherapy with PET: From Morphology to Metabolism.
Larissa B Costa, Marcelo A Queiroz, Felipe G Barbosa, Rafael F Nunes, Elaine C Zaniboni, Mariana Mazo Ruiz, Denis Jardim, Jose Flavio Gomes Marin, Giovanni G Cerri, Carlos A Buchpiguel. Radiographics 2021
6
40

PET imaging of immune checkpoint proteins in oncology.
Alizée Bouleau, Vincent Lebon, Charles Truillet. Pharmacol Ther 2021
5
40

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.
Frederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, Annelies Jorritsma-Smit, Ronald Boellaard, Iris C Kok, Sjoukje F Oosting, Carolina P Schröder, T Jeroen N Hiltermann, Anthonie J van der Wekken,[...]. Nat Med 2018
213
40

Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non-Small Cell Lung Cancer.
Lucian Beer, Maximilian Hochmair, Alexander R Haug, Bernhard Schwabel, Daria Kifjak, Wolfgang Wadsak, Thorsten Fuereder, Hannah Fabikan, Andreas Fazekas, Sophia Schwab,[...]. Clin Nucl Med 2019
23
40

ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.
Emily B Ehlerding, Christopher G England, Rebecca L Majewski, Hector F Valdovinos, Dawei Jiang, Glenn Liu, Douglas G McNeel, Robert J Nickles, Weibo Cai. Mol Pharm 2017
43
40

Predictive Power of a Radiomic Signature Based on 18F-FDG PET/CT Images for EGFR Mutational Status in NSCLC.
Xiaofeng Li, Guotao Yin, Yufan Zhang, Dong Dai, Jianjing Liu, Peihe Chen, Lei Zhu, Wenjuan Ma, Wengui Xu. Front Oncol 2019
32
40

Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.
Mengmeng Jiang, Yiqian Zhang, Junshen Xu, Min Ji, Yinglong Guo, Yixian Guo, Jie Xiao, Xiuzhong Yao, Hongcheng Shi, Mengsu Zeng. Nucl Med Commun 2019
10
40

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence.
Raju K Vaddepally, Prakash Kharel, Ramesh Pandey, Rohan Garje, Abhinav B Chandra. Cancers (Basel) 2020
271
40

Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis.
Flora Mulkey, Marc R Theoret, Patricia Keegan, Richard Pazdur, Rajeshwari Sridhara. J Immunother Cancer 2020
21
40

Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy.
Filippo Galli, Jesus Vera Aguilera, Belinda Palermo, Svetomir N Markovic, Paola Nisticò, Alberto Signore. J Exp Clin Cancer Res 2020
29
40

The Importance of Biopsy in the Era of Molecular Medicine.
Etay Ziv, Jeremy C Durack, Stephen B Solomon. Cancer J 2016
12
40

Targeted agents and immunotherapies: optimizing outcomes in melanoma.
Jason J Luke, Keith T Flaherty, Antoni Ribas, Georgina V Long. Nat Rev Clin Oncol 2017
553
40

Topography of cancer-associated immune cells in human solid tumors.
Jakob Nikolas Kather, Meggy Suarez-Carmona, Pornpimol Charoentong, Cleo-Aron Weis, Daniela Hirsch, Peter Bankhead, Marcel Horning, Dyke Ferber, Ivan Kel, Esther Herpel,[...]. Elife 2018
97
40

[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
Damijan Valentinuzzi, Martina Vrankar, Nina Boc, Valentina Ahac, Ziga Zupancic, Mojca Unk, Katja Skalic, Ivana Zagar, Andrej Studen, Urban Simoncic,[...]. Radiol Oncol 2020
14
40

18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma.
Kimiteru Ito, Rebecca Teng, Heiko Schöder, John L Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D Wolchok, Wolfgang A Weber. J Nucl Med 2019
63
40


Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis.
Yutian Zou, Xiaoqian Hu, Shaoquan Zheng, Anli Yang, Xing Li, Hailin Tang, Yanan Kong, Xiaoming Xie. EBioMedicine 2021
11
40

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy.
F Stephen Hodi, Marcus Ballinger, Benjamin Lyons, Jean-Charles Soria, Mizuki Nishino, Josep Tabernero, Thomas Powles, David Smith, Axel Hoos, Chris McKenna,[...]. J Clin Oncol 2018
149
40

Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes.
Jasmine A McQuerry, Jeffrey T Chang, David D L Bowtell, Adam Cohen, Andrea H Bild. J Mol Med (Berl) 2017
20
40


Artificial Neural Networks in Cardiovascular Diseases and its Potential for Clinical Application in Molecular Imaging.
Riccardo Laudicella, Albert Comelli, Alessandro Stefano, Monika Szostek, Ludovica Crocè, Antonio Vento, Alessandro Spataro, Alessio Danilo Comis, Flavia La Torre, Michele Gaeta,[...]. Curr Radiopharm 2021
3
66

The immune contexture in cancer prognosis and treatment.
Wolf H Fridman, Laurence Zitvogel, Catherine Sautès-Fridman, Guido Kroemer. Nat Rev Clin Oncol 2017
762
40

PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine.
Michael R Weist, Renate Starr, Brenda Aguilar, Junie Chea, Joshua K Miles, Erasmus Poku, Ethan Gerdts, Xin Yang, Saul J Priceman, Stephen J Forman,[...]. J Nucl Med 2018
61
40

Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.
Mohammad Rashidian, Jessica R Ingram, Michael Dougan, Anushka Dongre, Katherine A Whang, Camille LeGall, Juan J Cragnolini, Brian Bierie, Monica Gostissa, James Gorman,[...]. J Exp Med 2017
108
40

Novel Radiotracer for ImmunoPET Imaging of PD-1 Checkpoint Expression on Tumor Infiltrating Lymphocytes.
Arutselvan Natarajan, Aaron T Mayer, Lingyun Xu, Robert E Reeves, Jacob Gano, Sanjiv S Gambhir. Bioconjug Chem 2015
97
40

FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls.
Steve Y Cho, Daniel T Huff, Robert Jeraj, Mark R Albertini. Semin Nucl Med 2020
10
40

Cell Tracking in Cancer Immunotherapy.
Justine Perrin, Marisa Capitao, Marie Mougin-Degraef, François Guérard, Alain Faivre-Chauvet, Latifa Rbah-Vidal, Joëlle Gaschet, Yannick Guilloux, Françoise Kraeber-Bodéré, Michel Chérel,[...]. Front Med (Lausanne) 2020
19
40

A Systematic Review of PET Textural Analysis and Radiomics in Cancer.
Manuel Piñeiro-Fiel, Alexis Moscoso, Virginia Pubul, Álvaro Ruibal, Jesús Silva-Rodríguez, Pablo Aguiar. Diagnostics (Basel) 2021
5
40

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.
Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Thomas Lindner, Kazuhiro Ooe, Atsushi Toyoshima, Kojiro Nagata, Eku Shimosegawa, Uwe Haberkorn,[...]. J Nucl Med 2020
52
40


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.